Oscotec Inc.

Oscotec Inc. Share · KR7039200001 (XKOS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Oscotec Inc.
No Price
Closing Price XKOS 30.04.2026: 52.000,00 KRW
30.04.2026 06:30
Current Prices from Oscotec Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
039200.KQ
KRW
30.04.2026 06:30
52.000,00 KRW
-
Share Float & Liquidity
Free Float 82,94 %
Shares Float 31,73 M
Shares Outstanding 38,26 M
Invested Funds

The following funds have invested in Oscotec Inc.:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
101,16
Percentage (%)
0,10 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
21,08
Percentage (%)
0,0068 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
106,71
Percentage (%)
0,0068 %
Company Profile for Oscotec Inc. Share
Oscotec Inc. operates as a clinical stage drug discovery and development company. It develops SYK inhibitor that is in Phase IIa clinical trial to treat rheumatoid arthritis and immune thrombocytopenia; FLT3 inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia; and EGFR double mutation inhibitor to treat non-small cell lung cancer, as well as Anti-Tau antibody, which is in preclinical Phase for the treatment of Alzheimer's disease. The company also offers dental health products, such as bone graft comprising InduCera, BioCera-F, and SynCeraII; and membrane consisting of LysoGide and CollaGuide. In addition, it provides functional ingredients comprises OPB for osteoporosis; AIF for arthritis; SGA that enhance bone growth; and PRF-K for perio diseases. The company was formerly known as Oscotec Co., Ltd and changed its name to Oscotec Inc. in June 1999. Oscotec Inc. was founded in 1988 and is based in Seongnam, South Korea.

Company Data

Name Oscotec Inc.
Company Oscotec Inc.
Website https://www.oscotec.com
Primary Exchange XKOS KOSDAQ
ISIN KR7039200001
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Sung-Hee Son
Market Capitalization 1.989 Mrd.
Country South Korea
Currency KRW
Employees 0,1 T
Address A Building, Korea Bio Park, 13488 Seongnam-si
IPO Date 2007-01-17
Dividends from 'Oscotec Inc.'
Ex-Date Dividend per Share
29.12.2008 50,00 KRW
27.12.2007 100,00 KRW

Stock Splits

Date Split
27.09.2022 523:500
19.09.2012 217:200
29.12.2009 2:1
17.11.2009 513:500

Ticker Symbols

Name Symbol
KOSDAQ 039200.KQ
More Shares
Investors who hold Oscotec Inc. also have the following shares in their portfolio:
Direxion Daily Semiconductor Bear 3x Shares
Direxion Daily Semiconductor Bear 3x Shares ETF
Spree Acquisition Corp. 1 Limited
Spree Acquisition Corp. 1 Limited Share